ENDRA Life Sciences (NDRA) Treasury Shares (2016 - 2022)

ENDRA Life Sciences (NDRA) has 7 years of Treasury Shares data on file, last reported at $2.4 million in Q1 2022.

• Treasury Shares for Q1 2022 came in at $2.4 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $2.4 million (changed N/A YoY), and the FY2021 annual result was $121818.0, down 98.05% from the prior year.
• Treasury Shares improved to $2.4 million in Q1 2022 per NDRA's latest filing, from $121818.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $13.5 million in Q4 2019 and troughed at $121818.0 in Q4 2021.
• A 5-year average of $5.2 million and a median of $2.6 million in 2018 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2019 and 2021: Treasury Shares surged 413.58% in 2019, then sank 98.05% in 2021.
• A 5-year view of Treasury Shares shows it stood at $2.6 million in 2018, then surged by 413.58% to $13.5 million in 2019, then plunged by 53.68% to $6.3 million in 2020, then slumped by 98.05% to $121818.0 in 2021, then surged by 1900.66% to $2.4 million in 2022.
• Business Quant data shows NDRA's Treasury Shares at $2.4 million in Q1 2022, $121818.0 in Q4 2021, and $2.4 million in Q2 2021.